[Expression of proliferating cell nucleus antigen and nm23 protein and their relation with metastasis in hepatocellular carcinoma].

Hunan Yi Ke Da Xue Xue Bao

Department of Pathology, Xiangya School of Medicine, Central South University, Changsha 410078, China.

Published: February 2003

Objective: To investigate the expression of proliferating cell nucleus antigen (PCNA) and nm23 protein in hepatocellular carcinoma (HCC) and their relation with metastasis.

Methods: The expression of PCNA and nm23 protein in 56 HCCs were detected by the immunohistochemical technique.

Results: Of the 56 HCCs, the expression strength of PCNA and nm23 protein were significantly related to the differentiation degree of HCC: the poorer the differentiation of HCC, the stronger the PCNA expression, and the weaker the nm23 protein expression. The correlation analysis indicated that the strength of the PCNA expression was negatively related to that of nm23 (P < 0.01). The intensity of PCNA expression in HCCs with metastasis was significantly higher than that in HCCs without metastasis (P < 0.01), which was inverse with nm23 protein (P < 0.01).

Conclusion: The level of PCNA and nm23 protein may reflect the differentiation degree and metastasis potential of HCC, and may be one of the useful parameters for judging prognosis of HCC.

Download full-text PDF

Source

Publication Analysis

Top Keywords

nm23 protein
28
pcna nm23
16
pcna expression
12
proliferating cell
8
cell nucleus
8
nucleus antigen
8
nm23
8
strength pcna
8
differentiation degree
8
hccs metastasis
8

Similar Publications

c-MYC is a proto-oncogene ubiquitously overexpressed in various cancers. The formation of G-quadruplex (G4) structures within the c-MYC promoter region can regulate its transcription by interfering with protein binding. Consequently, small molecules targeting c-MYC G4 have emerged as promising anticancer agents.

View Article and Find Full Text PDF

Mechanistic Insights into Substrate Recognition of Human Nucleoside Diphosphate Kinase C Based on Nucleotide-Induced Structural Changes.

Int J Mol Sci

September 2024

Experimental Pharmacology Mannheim, European Center for Angioscience, Medical Faculty Mannheim, Heidelberg University, Ludolf-Krehl-Str. 13-17, 68167 Mannheim, Germany.

Nucleoside diphosphate kinases (NDPKs) are encoded by genes and exist in various isoforms. Based on interactions with other proteins, they are involved in signal transduction, development and pathological processes such as tumorigenesis, metastasis and heart failure. In this study, we report a 1.

View Article and Find Full Text PDF

NME6 belongs to the family of nucleoside diphosphate kinase enzymes, whose major role is to transfer the terminal phosphate from NTPs, mostly ATP, to other (d)NDPs via a high-energy intermediate. Beside this basic enzymatic activity, the family, comprising 10 genes/proteins in humans, executes a number of diverse biochemical/biological functions in the cell. A few previous studies have reported that NME6 resides in the mitochondria and influences oxidative phosphorylation while interacting with RCC1L, a GTPase involved in mitochondrial ribosome assembly and translation.

View Article and Find Full Text PDF

Eukaryotic NMEs/NDP kinases are a family of 10 multifunctional proteins that occur in different cellular compartments and interact with various cellular components (proteins, membranes, and DNA). In contrast to the well-studied Group I NMEs (NME1-4), little is known about the more divergent Group II NMEs (NME5-9). Three recent publications now shed new light on NME6.

View Article and Find Full Text PDF

Non-small cell lung cancer (NSCLC) is the most common malignancy worldwide, with a high death rate. Long noncoding RNA (LncRNA) NKX2-1 antisense RNA 1 (NKX2-1-AS1) has been reported to be an oncogene in lung tumorigenesis. However, the precise mechanism of NKX2-1-AS1 underlying NSCLC progression is blurry.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!